Arthur Klausner

Life Sciences Executive and Investor

An experienced life sciences executive and investor, Arthur Klausner currently serves as Executive Chairman of Concarlo Therapeutics (oncology). He is the former CEO of Goldilocks Therapeutics (nephrology), Gem Pharmaceuticals (oncology – acquired by Monopar Therapeutics), and Jade Therapeutics (ophthalmology – acquired by Kiora Pharmaceuticals). Before his operating roles, Arthur spent a total of 18 years as a life sciences venture capitalist at Domain Associates and Pappas Ventures.